| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_chr7_0399100 | Intergenic-Intergenic | chr7:40132810-40133821 | chr7:40093211-40094222 | 120 nt | 0.5500 |
| hsa_chr7_0399200 | Intergenic-Intergenic | chr7:40133901-40134062 | chr7:40094302-40094463 | 162 nt | 0.5000 |
| hsa_CDK13_0015000 | Exon-Exon | chr7:40133996-40135248 | chr7:40094397-40095649 | 1253 nt | 0.3935 |
| hsa_chr7_0399400 | Intergenic-Intergenic | chr7:40134931-40135120 | chr7:40095332-40095521 | 190 nt | 0.3737 |
| hsa_CDK13_0015100 | Exon-Intergenic | chr7:40136499-40142982 | chr7:40096900-40103383 | 157 nt | 0.3376 |
A study in mice and human cells demonstrated that the circCDK13 interacts with IGF2BP3 in an m6A-dependent manner to enhance its stability, promoting fibroblast and keratinocyte proliferation and migration, which accelerates diabetic wound healing [Zhang et al. DOI:10.7150/ijbs.114988].